On-Demand Webinars

  1. Regulatory, Cost Implications Of Switching Injectable Delivery Formats

    Launching a large molecule in one format and then switching the delivery format often transpires as a lifecycle management strategy for cost efficiency, supply chain continuity, and patient benefit. 

  2. De-Risking The Aseptic Drug-Filling Process And Optimizing Production 4/17/2024

    Aseptic drug-filling poses significant risks for manufacturers that can increase costs and timelines. Leveraging proven expertise and efficiency can ensure the production of safe, efficacious products.

  3. A Roadmap For Early Development To Commercial Manufacturing

    Learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach, with industry experts sharing key considerations when planning for scale-up of a development program.

  4. Identify And Mitigate Absorption Risks With PBPK Modeling 3/12/2024

    See how PBPK models combined with custom and off-the-shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.

  5. Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders

    Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

  6. Optimizing Pediatric Product Development For Commercialization Success 4/10/2024

    Ensuring medication adherence in pediatric patients presents challenges for pharmacotherapy. Explore various dosing solutions and learn how to streamline your pediatric development journey.

  7. Novel Applications In Pharmaceutical Spray Drying 3/10/2025

    Whether working with small-scale formulations or preparing for commercial manufacturing, this session will provide actionable strategies to optimize development pipelines.

  8. Survival Kit For Quality Regulations: A Closer Look At Lyo Packaging

    Explore primary packaging developed following well-established ICH principles for sustainable compliance and vial container closure systems for product development and commercial manufacturing needs.

  9. Selecting Containers For Sensitive And Costly Cell & Gene Therapies

    Explore the challenges related to packaging of cell and gene therapy products and proven solutions to enable speed to market and compatibility, performance of packaging materials.

  10. Development And Scale Up Of Insoluble, Microbially Expressed Biologics

    Delve into the use of inclusion bodies within biopharmaceutical production, which are now gaining attention for their potential in producing a range of difficult to express proteins in E. coli systems.